
Pangenomic Health Inc.
Pangenomic Health Inc. (NARA.CN) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
nara.cn · pe ratio · data through Jun 10, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Medical - Healthcare Information Services · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Pangenomic Health Inc.You NARA.CN | $5M | N/A | — | — |
AI/ML Innovations Inc. AIML.CN | $8M | N/A | — | -$0.03 |
Britannia Life Sciences Inc. BLAB.CN | $14M | 1.65x | — | $0.05 |
Comprehensive Healthcare Systems, Inc. CHS.V | $10M | N/A | — | -$0.15 |
Rapid Dose Therapeutics Corp. DOSE.CN | $12M | N/A | — | -$0.04 |
Hemostemix Inc. HEM.V | $11M | N/A | — | -$0.03 |
PreveCeutical Medical Inc. PREV.CN | $9M | N/A | — | -$0.00 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Pangenomic Health Inc. (NARA.CN) measures how much investors pay for each dollar of the company's trailing earnings. NARA.CN's current PE ratio of N/A is calculated by dividing its stock price of $0.33 by its TTM earnings per share of —.
Frequently asked questions
NARA.CN pe ratio · 6 questionsNARA.CN's current PE ratio is N/A as of 2026-06-10, based on a stock price of $0.33 and TTM EPS of —. Data sourced from Financial Modeling Prep via NARA.CN's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Pangenomic Health Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-10